Evidence map›Paper›PMID 39816053›Full record

Trial reportNarra J2024

Effects of

Wisnu Barlianto, Desy Wulandari, Tita L Sari, Rafika R Rachmaningrum, Rayi I Asasain

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Narra J, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wisnu BarliantoDivision of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
Desy WulandariDivision of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
Tita L SariDepartment of Pediatrics, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
Rafika R RachmaningrumDepartment of Pediatrics, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
Rayi I AsasainDepartment of Pediatrics, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse manifestations, requiring long-term treatment that can have side effects, particularly in pediatric patients.

Indexed as

CytokinesLupus Erythematosus, SystemicNigella sativaPlant OilsT-LymphocytesAdolescentCarumChildDouble-Blind MethodFemaleHumansMalecaraway oilCytokinesPlant OilscytokineimmunomodulatoryNigella sativapediatric SLET lymphocyte

Identifiers

PMID39816053
PMCPMC11731933

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.